share_log

Unicycive Announces Exclusive License, Development Agreement With Lotus For Renazorb In Republic Of Korea

Unicycive Announces Exclusive License, Development Agreement With Lotus For Renazorb In Republic Of Korea

獨家許可,與蓮花 Renazorb 在韓國宣布獨家許可,開發協議
Benzinga Real-time News ·  2023/02/02 08:39

Develops Renazorb opportunity in new market for patients with hyperphosphatemia

為高磷血症患者開發 Renazorb 在新市場上的機會

Agreement includes upfront payment, royalties, and milestone payments

協議包括預付款,特許權使用費和里程碑付款

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論